Latest Insider Transactions at Allovir, Inc. (ALVR)
This section provides a real-time view of insider transactions for Allovir, Inc. (ALVR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allovir, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allovir, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
17,915
-0.64%
|
$662,855
$37.72 P/Share
|
|
Mar 03
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
15,988
-0.23%
|
$591,556
$37.95 P/Share
|
|
Mar 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
512
-0.11%
|
$18,944
$37.93 P/Share
|
|
Mar 02
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
12,658
-0.45%
|
$481,004
$38.25 P/Share
|
|
Mar 02
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,994
-0.21%
|
$569,772
$38.23 P/Share
|
|
Mar 01
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
21,694
-1.13%
|
$824,372
$38.7 P/Share
|
|
Mar 01
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
9,518
-0.19%
|
$361,684
$38.82 P/Share
|
|
Mar 01
2021
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Indirect |
6,000
-1.52%
|
$228,000
$38.86 P/Share
|
|
Mar 01
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,932
-0.6%
|
$225,416
$38.91 P/Share
|
|
Mar 01
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
32,854
-0.46%
|
$1,248,452
$38.84 P/Share
|
|
Feb 23
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
8,489
-0.22%
|
$331,071
$39.95 P/Share
|
|
Feb 23
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
4,199
-0.06%
|
$163,761
$39.66 P/Share
|
|
Feb 23
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,118
-0.21%
|
$82,602
$39.75 P/Share
|
|
Feb 23
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,850
-0.09%
|
$345,150
$39.64 P/Share
|
|
Feb 22
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
800
-1.22%
|
$34,400
$43.14 P/Share
|
|
Feb 22
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,423
-0.39%
|
$479,766
$42.59 P/Share
|
|
Feb 22
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
5,706
-0.12%
|
$239,652
$42.19 P/Share
|
|
Feb 22
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,800
-0.28%
|
$117,600
$42.17 P/Share
|
|
Feb 22
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
14,321
-0.2%
|
$601,482
$42.59 P/Share
|
|
Feb 19
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
11,990
-1.2%
|
$491,590
$41.78 P/Share
|
|
Feb 19
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
7,541
-0.3%
|
$309,181
$41.75 P/Share
|
|
Feb 19
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,165
-0.83%
|
$170,765
$41.71 P/Share
|
|
Feb 19
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
13,233
-0.54%
|
$542,553
$41.79 P/Share
|
|
Feb 18
2021
|
Jeffrey S Bornstein |
SELL
Open market or private sale
|
Indirect |
20,583
-98.03%
|
$823,320
$40.83 P/Share
|
|
Feb 18
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
6,757
-0.22%
|
$270,280
$40.5 P/Share
|
|
Feb 18
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
8,942
-0.12%
|
$357,680
$40.47 P/Share
|
|
Feb 18
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,085
-0.14%
|
$83,400
$40.59 P/Share
|
|
Feb 18
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
741
-0.56%
|
$28,899
$39.87 P/Share
|
|
Feb 18
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,700
-0.04%
|
$108,000
$40.38 P/Share
|
|
Feb 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,496
-0.69%
|
$699,840
$40.11 P/Share
|
|
Feb 17
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,320
-0.85%
|
$92,800
$40.32 P/Share
|
|
Feb 17
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,286
-0.03%
|
$89,154
$39.92 P/Share
|
|
Feb 17
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
5,165
-0.13%
|
$206,600
$40.48 P/Share
|
|
Feb 17
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
7,460
-0.1%
|
$290,940
$39.99 P/Share
|
|
Feb 16
2021
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,050
-2.14%
|
$128,100
$42.24 P/Share
|
|
Feb 16
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,100
-0.3%
|
$130,200
$42.14 P/Share
|
|
Feb 16
2021
|
Ann M. Leen Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
3,050
-0.06%
|
$128,100
$42.31 P/Share
|
|
Feb 16
2021
|
Malcolm Brenner |
SELL
Open market or private sale
|
Indirect |
6,220
-0.2%
|
$261,240
$42.38 P/Share
|
|
Feb 16
2021
|
Juan Vera |
SELL
Open market or private sale
|
Direct |
10,400
-0.21%
|
$436,800
$42.16 P/Share
|
|
Feb 02
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
54,849
-9.54%
|
$2,248,809
$41.19 P/Share
|
|
Feb 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
48,910
-8.74%
|
$2,005,310
$41.19 P/Share
|
|
Jan 21
2021
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+6.18%
|
-
|
|
Jan 19
2021
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+5.89%
|
-
|
|
Jan 19
2021
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+12.61%
|
-
|
|
Jan 19
2021
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+50.0%
|
-
|
|
Jan 19
2021
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+19.62%
|
-
|
|
Jan 19
2021
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
58,800
+6.36%
|
-
|
|
Jan 19
2021
|
Agustin Melian Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+7.07%
|
-
|
|
Jan 19
2021
|
Ercem Atillasoy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+20.82%
|
-
|
|
Dec 01
2020
|
Edward Miller General Counsel |
BUY
Bona fide gift
|
Indirect |
41,514
+17.27%
|
-
|